Neuroscience News and Research

RSS

Experts formulate research related to psychological adjustment and traumatic brain injury

Five U.S. federal agencies recently cosponsored a set of expert work groups to formulate common data elements for research related to psychological adjustment and traumatic brain injury (TBI).

19 Nov 2010

New findings show promising treatment for MS

Successfully treating and reversing the effects of multiple sclerosis, or MS, may one day be possible using a drug originally developed to treat chronic pain, according to Distinguished Professor Linda Watkins of the University of Colorado at Boulder.

19 Nov 2010

Spleen cells may do more harm than good at site of spinal cord injury

The spleen, an organ that helps the body fight infections, might also be a source of the cells that end up doing more harm than good at the site of a spinal cord injury, new research suggests.

18 Nov 2010

Back pain sufferers get quicker diagnosis and treatment when examined by Nurse Practitioner

Results of a Toronto Western Hospital study show that patients suffering back pain get quicker diagnosis and treatment when a Nurse Practitioner conducts the first examination. Traditionally, patients face long and anxiety-ridden wait times - up to 52 weeks - before an initial examination by a spine surgeon. Results from the year long TWH study showed wait times for patients examined by a Nurse Practitioner were significantly shorter, ranging from 10 to 21 weeks.

18 Nov 2010

Dim light at night linked to depression

Exposure to even dim light at night is enough to cause physical changes in the brains of hamsters that may be associated with depression, a new study shows.

18 Nov 2010

Naurex's antidepressant shares efficacy mechanisms with NMDA receptor antagonist ketamine

Naurex Inc., a company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported that data presented at Neuroscience 2010 show that GLYX-13, its clinical-stage candidate for the treatment of depression, shares key mechanistic features associated with the antidepressant efficacy of the NMDA receptor antagonist ketamine.

18 Nov 2010

Study reveals introspection anchored in specific part of brain

A new study reveals that 'introspection' (thinking about our own thoughts or behaviour) is anchored in a specific part of our brain. The research by scientists from the Institute of Cognitive Neuroscience and the Wellcome Trust Centre for Neuroimaging at UCL (University College London) examined people's accuracy when reflecting on decisions they had made.

18 Nov 2010

State-of-the-art imaging system helps locate and count myriad connections between brain nerve cells

Researchers at the Stanford University School of Medicine, applying a state-of-the-art imaging system to brain-tissue samples from mice, have been able to quickly and accurately locate and count the myriad connections between nerve cells in unprecedented detail, as well as to capture and catalog those connections' surprising variety.

18 Nov 2010

Cigarette smoke, automobile exhaust and french fries increase risk of developing Alzheimer's disease

There is growing evidence that exposure to a group of chemicals known as type-2 alkenes -- which are found in the smoke inhaled from cigarettes, the exhaust of automobiles and even in French fries - can increase the chances of developing Alzheimer's disease and other neurological conditions such as Parkinson's disease.

18 Nov 2010

Researchers discover NG2+ cells may impact ALS disease progression

By tracking the fate of a group of immature cells that persist in the adult brain and spinal cord, Johns Hopkins researchers discovered in mice that these cells undergo dramatic changes in ALS, also known as Lou Gehrig's disease.

18 Nov 2010

Titan Pharmaceuticals presents data on Probuphine Phase 3 clinical program for opioid addiction at Neuroscience Meeting

Titan Pharmaceuticals, Inc. today announced that data from its Phase 3 clinical development program for Probuphine were presented at the Society for Neuroscience Annual Meeting, being held Nov. 13-17 in San Diego.

18 Nov 2010

Sangamo presents Phase 2 clinical data in ALS at Society for Neuroscience Meeting

Sangamo BioSciences, Inc. announced today the presentation of Phase 2 clinical data from its ZFP Therapeutic program to develop SB-509, a zinc finger protein transcriptional activator (ZFP-TF) of the vascular endothelial growth factor (VEGF)-A gene as a treatment for ALS.

17 Nov 2010

Prime Healthcare announces acquisition of Alvarado Hospital

Prime Healthcare Services, Inc., which owns and/or operates 13 acute care hospitals in California, announced the acquisition of Alvarado Hospital in San Diego, CA, from Plymouth Health, a privately-held, Los Angeles-based company that has owned and operated the hospital since January 2007.

17 Nov 2010

Studies explore lifestyle's influence on wellness and brain health

New research is providing a deeper understanding of how individual actions - such as exercising, sensory stimulation, or drinking - influence brain health and outcomes. This new knowledge could ultimately lead to interventions in age-related cognitive declines, drug abuse, stroke, and brain injury, separate from or in combination with traditional pharmacological approaches. These findings were presented at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.

17 Nov 2010

Artificial retinas, thought-controlled devices and brain stimulation therapy show promise

Two experimental brain-machine technologies - deep brain stimulation coupled with physical therapy and a thought-controlled computer system-may offer new therapies for people with stroke and brain injuries, new human research shows. In addition, an animal study shows a new artificial retina may restore vision better than existing prosthetics. The findings were announced today at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.

17 Nov 2010

Teen brain responds differently to drugs than adult

New research released today shows teenagers respond differently to drugs than adults and explores the long-lasting effects of drug use on brain development. One study shows people who start using drugs at a young age have greater cognitive shortfalls, including mental flexibility. Animal studies also suggest adolescents are more susceptible to lower doses of cocaine, are willing to work more for a cocaine "fix" than adults, and are at risk of developing compromised stress responses.

17 Nov 2010

Video game-based technologies allow new insight into memory, perception and motor control

New tools inspired by video games are revealing how the brain senses and responds to its surroundings, finds new human and animal research. Taking advantage of state-of-the art technologies to track and mimic real-life environments, these studies show with new detail how the brain navigates, identifies, and remembers a setting. In additional human research, scientists apply these same technological advances to help people who have experienced strokes regain skills.

17 Nov 2010

New findings suggest brain sensory regions overlap to help people interpret environment

New research indicates that the integration of senses and functions in the brain is common. About two percent of the population has a condition called synesthesia, in which two different sensations, like color and sound, are experienced at once.

17 Nov 2010

New insights into communication problems like stuttering

New human and animal studies released today uncover the extensive brain wiring used in communication and provide new insights into how the brain processes and produces language, accents, and sounds. The research also explores the brain abnormalities in people with speech and language problems, such as stuttering, suggesting future treatment avenues. The new findings were presented at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.

17 Nov 2010

Garvan Institute professor receives 2010 Prime Minister's Prize for Science

Professor John Shine AO FAA, Executive Director of Sydney's Garvan Institute of Medical Research, received the 2010 Prime Minister's Prize for Science, the nation's most highly respected award for scientific achievement, in Parliament House tonight.

17 Nov 2010

Neuroscience News and Research

Experts formulate research related to psychological adjustment and traumatic brain injury

New findings show promising treatment for MS

Spleen cells may do more harm than good at site of spinal cord injury

Back pain sufferers get quicker diagnosis and treatment when examined by Nurse Practitioner

Dim light at night linked to depression

Naurex's antidepressant shares efficacy mechanisms with NMDA receptor antagonist ketamine

Study reveals introspection anchored in specific part of brain

State-of-the-art imaging system helps locate and count myriad connections between brain nerve cells

Cigarette smoke, automobile exhaust and french fries increase risk of developing Alzheimer's disease

Researchers discover NG2+ cells may impact ALS disease progression

Titan Pharmaceuticals presents data on Probuphine Phase 3 clinical program for opioid addiction at Neuroscience Meeting

Sangamo presents Phase 2 clinical data in ALS at Society for Neuroscience Meeting

Prime Healthcare announces acquisition of Alvarado Hospital

Studies explore lifestyle's influence on wellness and brain health

Artificial retinas, thought-controlled devices and brain stimulation therapy show promise

Teen brain responds differently to drugs than adult

Video game-based technologies allow new insight into memory, perception and motor control

New findings suggest brain sensory regions overlap to help people interpret environment

New insights into communication problems like stuttering

Garvan Institute professor receives 2010 Prime Minister's Prize for Science

Event guide: 8th Neuroimmunology Drug Development Summit 2026 eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News